• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润淋巴细胞、肿瘤芽生、肿瘤边界形态及肿瘤间质比例在结直肠癌中的预后作用

Prognostic Role of Tumor-Infiltrating Lymphocytes, Tumor Budding, Tumor Border Configuration, and Tumor Stroma Ratio in Colorectal Carcinoma.

作者信息

Pujani Mukta, Singh Kanika, Agarwal Charu, Chauhan Varsha, Prasad Sneha, Singh Mitasha, Wadhwa Ruchira, Yadav Alka

机构信息

Department of Pathology, ESIC Medical College & Hospital, Faridabad, Haryana India.

Department of Community Medicine, ESIC Medical College & Hospital, Faridabad, Haryana India.

出版信息

Indian J Surg Oncol. 2025 Apr;16(2):691-697. doi: 10.1007/s13193-024-02127-1. Epub 2024 Nov 8.

DOI:10.1007/s13193-024-02127-1
PMID:40337027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12052629/
Abstract

Histomorphological features like tumor-infiltrating lymphocytes (TIL), tumor budding (TB), tumor stroma ratio (TSR), and tumor border configuration (TBC) may provide important prognostic information for more accurate stratification and personalized therapeutic approach in colorectal cancer (CRC). The objective of the current study was to investigate the prognostic impact of novel histopathological features (TIL, TB, TBC, TSR) and a new combined risk score (CRS) in primary CRC. This cross-sectional observational study was conducted on hematoxylin and eosin (H&E)-stained slides of 65 primary CRC cases. Stromal TIL was categorized into 3 groups: low (0 to 10%), intermediate (15 to 50%), and high (55 to 100%). Tumor budding was counted in 10 HPFs and graded as follows: 0-4 buds-low TB, 5-9 buds-intermediate TB, and 10 or more buds-high TB. TBC was labeled as either pushing or infiltrative. TSR was scored into two groups as high TSR (low stroma as ≤ 50%) and low TSR (high stroma > 50%). A novel CRS was constructed based on TBC, TB, and TSR: Infiltrating TBC, TB score > 5 (median), and low TSR were categorized as risk items. Final categories were as follows: low-risk tumors with ≤ 1 risk item and high-risk tumors with > 1 risk items. TIL showed a significant correlation with histological tumor type; TB was significantly associated with tumor location, grade, T stage, and perineural invasion, while TBC significantly correlated with tumor location only. TSR showed significant association with tumor location and perineural invasion, while the combined risk score significantly correlated with tumor location and grade. Tumor border configuration, tumor budding, tumor stroma ratio, and the newly formed combined risk score are simple, cost-effective, potential markers in colorectal cancer patients, suggesting that their incorporation in the routine histopathological evaluation could be useful in determining the prognosis of colorectal cancer cases.

摘要

肿瘤浸润淋巴细胞(TIL)、肿瘤芽生(TB)、肿瘤间质比(TSR)和肿瘤边界形态(TBC)等组织形态学特征可为结直肠癌(CRC)更准确的分层和个性化治疗方法提供重要的预后信息。本研究的目的是调查新的组织病理学特征(TIL、TB、TBC、TSR)和新的综合风险评分(CRS)对原发性CRC的预后影响。这项横断面观察性研究对65例原发性CRC病例的苏木精和伊红(H&E)染色切片进行。基质TIL分为3组:低(0至10%)、中(15至50%)和高(55至100%)。在10个高倍视野(HPF)中计数肿瘤芽生,并分级如下:0 - 4个芽为低TB,5 - 9个芽为中TB,10个或更多芽为高TB。TBC标记为推挤型或浸润型。TSR分为两组,高TSR(低基质≤50%)和低TSR(高基质>50%)。基于TBC、TB和TSR构建了一个新的CRS:浸润性TBC、TB评分>5(中位数)和低TSR被归类为风险项目。最终分类如下:风险项目≤1的低风险肿瘤和风险项目>1的高风险肿瘤。TIL与组织学肿瘤类型显著相关;TB与肿瘤位置、分级、T分期和神经周围浸润显著相关,而TBC仅与肿瘤位置显著相关。TSR与肿瘤位置和神经周围浸润显著相关,而综合风险评分与肿瘤位置和分级显著相关。肿瘤边界形态、肿瘤芽生、肿瘤间质比和新形成的综合风险评分是结直肠癌患者简单、经济有效的潜在标志物,表明将它们纳入常规组织病理学评估可能有助于确定结直肠癌病例的预后。

相似文献

1
Prognostic Role of Tumor-Infiltrating Lymphocytes, Tumor Budding, Tumor Border Configuration, and Tumor Stroma Ratio in Colorectal Carcinoma.肿瘤浸润淋巴细胞、肿瘤芽生、肿瘤边界形态及肿瘤间质比例在结直肠癌中的预后作用
Indian J Surg Oncol. 2025 Apr;16(2):691-697. doi: 10.1007/s13193-024-02127-1. Epub 2024 Nov 8.
2
The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.促纤维增生性反应、肿瘤芽生及肿瘤浸润淋巴细胞在食管鳞状细胞癌中的预后意义
BMC Gastroenterol. 2025 Jul 1;25(1):476. doi: 10.1186/s12876-025-03984-y.
3
A Study on Cancer-Associated Fibroblast Using Alpha-Smooth Muscle Actin Immunohistochemistry in Oral Squamous Cell Carcinoma.一项使用α-平滑肌肌动蛋白免疫组织化学法对口腔鳞状细胞癌中癌症相关成纤维细胞的研究。
Cureus. 2025 May 29;17(5):e85027. doi: 10.7759/cureus.85027. eCollection 2025 May.
4
Prognostic Value of Tumor-Stroma Ratio in a Screened Stage II Colon Cancer Population: Intratumoral Site-Specific Assessment and Tumor Budding Synergy.肿瘤-间质比在筛查的II期结肠癌人群中的预后价值:瘤内特定部位评估及肿瘤芽生协同作用
Mod Pathol. 2025 Jun;38(6):100738. doi: 10.1016/j.modpat.2025.100738. Epub 2025 Feb 17.
5
Evaluation of tumor budding, desmoplastic reaction, and lymphocytic infiltration in predicting survival for pancreatic ductal adenocarcinoma.评估肿瘤芽生、促纤维增生性反应和淋巴细胞浸润对预测胰腺导管腺癌生存率的作用。
World J Gastrointest Oncol. 2025 Jun 15;17(6):107021. doi: 10.4251/wjgo.v17.i6.107021.
6
Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.实体瘤患者肿瘤-基质比与预后的关联:一项系统评价和荟萃分析。
Oncotarget. 2016 Oct 18;7(42):68954-68965. doi: 10.18632/oncotarget.12135.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Role of Preoperative Breast MRI in Predicting Tumor-Infiltrating Lymphocytes in Breast Cancer: Is There an Association with Tumor Biological Subtypes?术前乳腺磁共振成像在预测乳腺癌肿瘤浸润淋巴细胞中的作用:与肿瘤生物学亚型是否存在关联?
Biomedicines. 2025 Jun 2;13(6):1364. doi: 10.3390/biomedicines13061364.
10
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma.病理学家解读与人工智能驱动的黑色素瘤肿瘤浸润淋巴细胞评估
JAMA Netw Open. 2025 Jul 1;8(7):e2518906. doi: 10.1001/jamanetworkopen.2025.18906.

本文引用的文献

1
Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer.II期和III期结直肠癌中肿瘤浸润淋巴细胞与生存的相关性
Cureus. 2022 Nov 6;14(11):e31144. doi: 10.7759/cureus.31144. eCollection 2022 Nov.
2
The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma.结直肠癌中肿瘤边界形态、肿瘤芽和肿瘤间质比的预后影响。
Turk Patoloji Derg. 2023;39(1):83-93. doi: 10.5146/tjpath.2022.01579.
3
The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.肿瘤芽生在结直肠癌中的作用:肠道癌干细胞标志物Lgr5可能的参与情况。
Indian J Pathol Microbiol. 2020 Jan-Mar;63(1):32-37. doi: 10.4103/IJPM.IJPM_154_19.
4
Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases.结直肠癌原发肿瘤及其转移灶中的肿瘤浸润淋巴细胞
Exp Ther Med. 2019 Dec;18(6):4904-4912. doi: 10.3892/etm.2019.8146. Epub 2019 Oct 30.
5
Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 Patients.采用国际肿瘤浸润淋巴细胞工作组(ITWG)系统评估肿瘤浸润淋巴细胞是结直肠癌总生存的强有力预测因素:一项 1034 例患者的研究。
Am J Surg Pathol. 2020 Apr;44(4):536-544. doi: 10.1097/PAS.0000000000001409.
6
Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment.肿瘤芽预测新辅助治疗后直肠癌切除术后的预后。
World J Surg Oncol. 2019 Mar 14;17(1):50. doi: 10.1186/s12957-019-1588-6.
7
Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations.结肠癌中肿瘤间质比的评分:操作步骤与建议。
Virchows Arch. 2018 Oct;473(4):405-412. doi: 10.1007/s00428-018-2408-z. Epub 2018 Jul 20.
8
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.肿瘤基质比率和肿瘤芽生在II期结肠癌中的预后价值。一项基于全国人群的研究。
Int J Colorectal Dis. 2018 Aug;33(8):1115-1124. doi: 10.1007/s00384-018-3076-9. Epub 2018 May 21.
9
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.评估实体瘤中的肿瘤浸润淋巴细胞:病理学家实用综述及国际免疫肿瘤生物标志物工作组提出的标准化方法建议:第 2 部分:黑色素瘤、胃肠道癌、非小细胞肺癌和间皮瘤、子宫内膜癌和卵巢癌、头颈部鳞状细胞癌、泌尿生殖道癌和脑原发性肿瘤中的 TILs。
Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161.
10
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.基于 2016 年国际肿瘤芽殖共识会议(ITBCC)的结直肠癌肿瘤芽殖报告推荐建议。
Mod Pathol. 2017 Sep;30(9):1299-1311. doi: 10.1038/modpathol.2017.46. Epub 2017 May 26.